|
THE SCIENCE AND CLINICAL APPLICATIONS OF RED BLOOD CELL HEALTH IN SICKLE CELL DISEASE, COVID-19, AND BEYOND |
03/15/2022 - 8:00am to 9:00am EDT |
|
The Care for Patients with SCD in the Netherlands and Research on Environmental Modifiers of Sickle Cell Disease |
03/22/2022 - 8:00am to 9:00am EDT |
|
Sickle cell disease and malaria—similar Pathophysiolgies point to new/better therapies |
03/29/2022 - 8:00am to 9:00am EDT |
|
Why Professors Watson & Waldenstrom are Smiling: Update on Pathogenesis, Clinical Manifestations, and Management of Acute Porphyria, the Little Imitator |
04/05/2022 - 8:00am to 9:00am EDT |
|
The oral ferroportin inhibitor vamifeport improved hemodynamics in a mouse model of sickle cell disease |
04/12/2022 - 8:00am to 9:00am EDT |
|
Hematology Case Conference 2022 |
04/19/2022 - 8:00am to 9:00am EDT |
|
Hematology Case Conference 2022 |
04/26/2022 - 8:00am to 9:00am EDT |
|
Hematology Case Conference 2022 |
05/03/2022 - 8:00am to 9:00am EDT |
|
Hematology Case Conference 2022 |
05/10/2022 - 8:00am to 9:00am EDT |
|
Hematology Case Conference 2022 |
05/17/2022 - 8:00am to 9:00am EDT |
